Anaesthesia makes up the largest hospital speciality and has a huge role to play in nearly every aspect of any hospital from operating theatres to accident and emergency, to the labour ward, and to intensive care. Our research ranges from basic molecular research into mechanisms of anaesthesia to investigating the clinical impact of novel anaesthetic agents.
Our research covers the entirety of patient’s perioperative journey and through this, we aim to deliver the greatest impact. The section has been pioneering in the development of novel technologies to facilitate the delivery of anaesthetic agents and has also made pivotal in-roads into the mechanism of action of anaesthetic agents and their wider application to other diseases (such as their protective roles in brain injury and in cancer).
@inproceedings{Harris:2016:10.3109/02699052.2016.1162060,
author = {Harris, K and Armstrong, S and Campos-Pires, R and Kiru, L and Franks, N and Dickinson, R},
doi = {10.3109/02699052.2016.1162060},
pages = {606--606},
publisher = {Taylor & Francis},
title = {Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site},
url = {http://dx.doi.org/10.3109/02699052.2016.1162060},
year = {2016}
}
TY - CPAPER
AU - Harris,K
AU - Armstrong,S
AU - Campos-Pires,R
AU - Kiru,L
AU - Franks,N
AU - Dickinson,R
DO - 10.3109/02699052.2016.1162060
EP - 606
PB - Taylor & Francis
PY - 2016///
SN - 1362-301X
SP - 606
TI - Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site
UR - http://dx.doi.org/10.3109/02699052.2016.1162060
ER -